Dr. Anand Kumar Rohatgi, MD

Dr. Rohatgi practices at University of Texas Southwestern Medical Center at Dallas in Dallas, Texas.

Dr. Rohatgi's NPI, 1427173533, was assigned on March 20, 2007. Dr. Rohatgi graduated from Duke University School Of Medicine in 2002. Dr. Rohatgi holds Texas license M6856.

Dr. Rohatgi's primary practice is University of Texas Southwestern Medical Center at Dallas, at 2001 Inwood Rd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 645-0624.

Dr. Rohatgi's primary practice is University of Texas Southwestern Medical Center at Dallas in Dallas, Texas. Dr. Rohatgi is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Rohatgi to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rohatgi practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Rohatgi's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Rohatgi is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Rohatgi's licenses on file in 2 states: Texas and Pennsylvania.

Dmand AI lists cardiac arrhythmia, cerebrovascular disease, chronic hypertension, congestive heart failure, coronary artery disease, high cholesterol, hypertension and peripheral vascular disease among the conditions Dr. Rohatgi treats.

CMS data shows 426 Medicare services from Dr. Rohatgi across 7 procedure codes in 2024, for 372 Medicare patients. Medicare paid $18,379 for them.

CMS counts 372 Medicare patients who saw Dr. Rohatgi in 2024. The largest group is 65 to 74, with 153 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rohatgi's median patient age at 57, with 50% women.

In 2024, Dr. Rohatgi wrote 440 Medicare Part D claims for 88 patients. 75% of them were for generic drugs. CMS names the drug for 315 of them, across 12 drugs with 11 or more claims each, at $68,366 in total drug cost. In 2023, CMS named 430 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Rohatgi for performance year 2024, reported as part of a group. Dr. Rohatgi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rohatgi as offering telehealth.

Dmand AI links 113 papers to Dr. Rohatgi, published from 2005 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Atherosclerosis, Cardiovascular Diseases and Cholesterol, HDL. Dr. Rohatgi has published most often in Circulation. Dr. Rohatgi's most frequent co-authors are James Andrew De Lemos, MD, Amit Khera, MD, MS and Sandeep Ram Das, MD.

Dmand AI links Dr. Rohatgi to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Atherosclerosis, Cardiovascular Diseases and Coronary Artery Disease. University of Texas Southwestern Medical Center sponsors the most, 2.

CMS Open Payments shows 24 general payments to Dr. Rohatgi from 5 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 56% of the total. CSL Behring paid the most, $6,219.

Dmand AI lists 2 awards for Dr. Rohatgi, most recently CMS Stage 1 EHR in 2012.

Dr. Rohatgi graduated from Duke University School Of Medicine in 2002. Dr. Rohatgi is a member of ACC and AHA.

Dr. Rohatgi is in network with 22 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.